好色先生

好色先生

Explore the latest content from across our publications
Join The AAN

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Evaluation of Lacosamide Efficacy in Subjects with Difficult-to-Treat Partial-Onset Seizures across the Dose Range Used in Phase II/III Clinical Trials
Epilepsy
(-)
115
Authors/Disclosures
Steve Chung, MD, FAAN (Banner University Medical Center) The institution of Dr. Chung has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for ucb pharma. Dr. Chung has received personal compensation in the range of $500-$4,999 for serving as a Consultant for SK Life sciences. Dr. Chung has received personal compensation in the range of $500-$4,999 for serving as a Consultant for eisai. Dr. Chung has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for eisai. Dr. Chung has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for ucb. Dr. Chung has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for SK Life sciences. Dr. Chung has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for sunovion.
G. David Rudd, PharmD, MS (G David Rudd LLC) No disclosure on file
No disclosure on file
Pamela Doty, PhD No disclosure on file
No disclosure on file